Work

Computational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in Melanoma

Year: 2021

Type: article

Study design: Observational Study

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2020.12.015

Authors: Wesley Y. Yu, Sheena T. Hill, E. Ricky Chan, John J. Pink, Kevin Cooper, Sancy Leachman, Amanda W. Lund, Rajan Kulkarni, Jeremy S. Bordeaux

Institutions: Oregon Health & Science University, University Hospitals Cleveland Medical Center, Case Western Reserve University, Case Comprehensive Cancer Center, OHSU Knight Cancer Institute, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University

Language: English

Topic: Cancer, Lipids, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, American Cancer Society, Cancer Research Institute, Melanoma Research Alliance, Case Comprehensive Cancer Center, Case Western Reserve University, Engineering Research Centers, National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: CLINICAL AND BIOLOGICAL INSIGHT INTO MAPK SIGNALING AND TUMOR HETEROGENEITY USING CIRCULATING TUMOR BIOMARKERS, G2244966566, EVALUATING HETEROGENEITY AND RESPONSE TO TREATMENT IN MELANOMA USING CIRCULATING TUMOR CELLS, G7209479504, Clinical and Translational Science Collaborative of Cleveland, Case Comprehensive Cancer Center Support Grant

OpenAlex ID: W3118238985

FWCI: 0.988

Cites: 61

Cited by: 16

Related to: 10